Episode 23: ASCO Annual Meeting 2025 Commentary: Kidney Cancer

episode

The View on GU | with Lalani and Wallis not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 9AM EDT 5 min · 24 Sep 2026 · NPR News Now

9AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

The Critic Who Finally Came Around | Jeanine Pt. 5 6 min · 24 Sep 2026 · The Best 5 Minute Wine Podcast

Ambitious But Lazy? Use This CIA Trick to Beat 99% of People 19 min · 24 Sep 2026 · EverydaySpy Podcast

Postpartum Fitness & My Boob Job… 1h 15m · 24 Sep 2026 · Pursuit of Wellness

326. Rethinks: The Secrets to Getting the Information You Need from AI 28 min · 24 Sep 2026 · Think Fast Talk Smart: Communication Techniques

Report any issue

Source

Recorded05 Jun 2025

Publisheranchor.fm ↗

Handlerec:12292686

Show notes

Recorded live in Chicago, your hosts explore the latest in kidney cancer, discussing new five-year follow-up data from KEYNOTE-564, the long-term results of CheckMate 214, insights from the ongoing PDIGREE trial, and much more.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in